Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona

Posted : Thu, 05 Nov 2009 01:15:38 GMT
Author : Abraxis BioScience, Inc.
Category : Press Release
News Alerts by Email ( click here )
News | Home
LOS ANGELES - (Business Wire) Abraxis Health, a fully-integrated personalized healthcare division of Abraxis BioScience, Inc. (NASDAQ:ABII), today announced the dedication of its new manufacturing facility in Phoenix, Arizona. The state of the art biopharma manufacturing plant represents a $70 million investment by LA-based Abraxis, and will create up to 200 high tech jobs. The new facility will manufacture ABRAXANE®, the first solvent-free chemotherapy treatment option for metastatic breast cancer, which was developed using Abraxis BioScience's proprietary nab® technology platform. The company now has multiple agreements in place for the development of novel, insoluble compounds using the nanobiologics technology employed at the Phoenix plant.

The facility will be the world’s largest and most sophisticated protein nanobiologics manufacturing plant, with annual production capacity of over 10 million units, and the capability to expand to 20 million units, suitable for worldwide distribution. The site, formerly owned by Watson Pharmaceuticals, was purchased by Abraxis in July 2007. Abraxis has hired more than 100 former Watson employees, recruited additional staff from among the local skilled workforce, and will continue to recruit as the facility ramps up production.

"The outlook for Abraxis is immensely encouraging," said founder and Chairman Dr. Patrick Soon-Shiong. “As we continue to grow, these new premises in Phoenix will become the flagship manufacturing facility for our cutting edge technology."

State Attorney General Terry Goddard commented, “Arizona is proud to welcome Abraxis as a powerful new addition to our growing life sciences sector.”

"This is great news for Phoenix," said Mayor Phil Gordon. "We are delighted that Abraxis has chosen our city for this state of the art nanotech manufacturing plant, bringing highly skilled jobs and a welcome boost for our economy.”

State, city and business leaders attended today’s ceremony to dedicate the new facility, including Attorney General Goddard and Mayor Phil Gordon.

About Abraxis BioScience, Inc.

Abraxis Health, which will operate the Phoenix facility, is a division of Abraxis Bioscience Inc. Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes the world's first and only protein-bound nanoparticle chemotherapeutic compound (ABRAXANE®), which is based on the company's proprietary tumor targeting technology known as the nab® platform. The first FDA approved product to use this nab platform, ABRAXANE, was launched in 2005 for the treatment of metastatic breast cancer and is now approved in 38 countries. The company continues to expand the nab platform through a robust clinical program and deep product pipeline. Abraxis trades on the NASDAQ Global Market under the symbol ABII. For more information about the company and its products, please visit www.abraxisbio.com.

Investors and Media Inquiries:
Abraxis BioScience, Inc.
Maili Bergman, 310-883-1300
investorrelations@abraxisbio.com


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

ClearOne Granted Amended Permanent Injunction Order in Federal Trade Secret Misappropriation Case; Contempt Order Issued Against DialHD, Inc., Wideband Solutions, Inc., and Others
SALT LAKE CITY, Nov. 22 -- (Nasdaq: CLRO) An Amended Permanent Injunction was issued by the federal court on November 19, 2009, in favor of ClearOne, expanding the scope of an earlier entered permanent injunction to apply to, among others, the products of Dial...

Jimmie Johnson Makes History By Capturing Fourth Consecutive Sprint Cup Title
HOUSTON, Nov. 22 /PRNewswire/ -- Hendrick Motorsports driver Jimmie Johnson made history on Sunday by capturing his fourth consecutive NASCAR Sprint Cup Series championship. For the fourth year in a row, he powered his No. 48 Lowe's Chevrolet to the highest level in NASCAR comp...

Flood victim pensioners and uninsured to get free expert assistance from Claimtech
The latest UK flooding will no doubt reflect the terrible treatment the flood victims received in the Carlisle 2004 and 2007 NE floods. Today as then, the UK still has no recognised training or standards for the flood restoration industry and properties can be left with health hazards and ...

Endsleigh Reveals the Main Causes of Car Accidents in Winter
The weather has turned for the worse in the UK as winter tightens its grip and during the colder months driving does become more hazardous, but by adhering to some of these tips from Endsleigh Car Insurance it doesn’t have to be./I/P P(PRWeb UK) November 22, 2009 -- Here are some ...

Terra Industries Board of Directors Comments on CF Industries’ Latest Approach
SIOUX CITY, Iowa - Terra Industries Inc. (NYSE:TRA) today announced that, over the weekend, CF Industries Holdings, Inc. (NYSE: CF) submitted a proposed merger agreement to Terra, containing the same economic terms as its most recent proposal from November 1, together with a 30-day “go

REMINDER: Media Advisory: LAX FlyAway(R) Service Formally Inaugurates Daily Nonstop Bus Service to Irvine, Six Times Daily
LOS ANGELES, CA -- 11/22/09 -- WHAT: Los Angeles Mayor Antonio R. Villaraigosa will be joined by officials from the City of Irvine and Orange County transportation agencies to formally inaugurate the ne..

Maxprog Releases New MaxBulk Mailer 7
Maxprog is proud to present a new release of MaxBulk Mailer, new version 7, available now on Maxprog website with several interesting new features and improvements. MaxBulk Mailer is an email-merge solution for Macintosh and Windows that supports plain text, HTML and rich text formats includi...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.